Ellington Financial (EFC) Now Covered By Sandler O’Neill with $17.00 Target; Ani Pharmaceuticals (ANIP) Shorts Down By 0.46%

December 6, 2017 - By Kurt Siggers

Among 6 analysts covering Ellington Financial (NYSE:EFC), 2 have Buy rating, 0 Sell and 4 Hold. Therefore 33% are positive. Ellington Financial has $23.0 highest and $16.0 lowest target. $17.90’s average target is 20.05% above currents $14.91 stock price. Ellington Financial had 18 analyst reports since August 10, 2015 according to SRatingsIntel. Maxim Group maintained it with “Buy” rating and $20 target in Tuesday, October 11 report. The firm has “Hold” rating by Keefe Bruyette & Woods given on Tuesday, September 12. Maxim Group maintained the stock with “Buy” rating in Tuesday, July 11 report. Maxim Group maintained the stock with “Buy” rating in Thursday, February 18 report. The rating was maintained by Maxim Group with “Buy” on Friday, August 4. The rating was maintained by Maxim Group with “Buy” on Monday, August 10. The firm has “Buy” rating given on Tuesday, November 7 by Maxim Group. FBR Capital initiated the stock with “Outperform” rating in Thursday, April 21 report. The stock has “Buy” rating by Maxim Group on Monday, October 9. The rating was maintained by Maxim Group with “Buy” on Thursday, August 13.

Ani Pharmaceuticals Incorporated (NASDAQ:ANIP) had a decrease of 0.46% in short interest. ANIP’s SI was 961,900 shares in December as released by FINRA. Its down 0.46% from 966,300 shares previously. With 118,500 avg volume, 8 days are for Ani Pharmaceuticals Incorporated (NASDAQ:ANIP)’s short sellers to cover ANIP’s short positions. The SI to Ani Pharmaceuticals Incorporated’s float is 10.83%. The stock decreased 1.86% or $1.28 during the last trading session, reaching $67.62. About 52,456 shares traded. ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) has declined 0.02% since December 6, 2016 and is downtrending. It has underperformed by 16.72% the S&P500.

Ellington Financial LLC, through its subsidiary Ellington Financial Operating Partnership LLC, operates as a specialty finance firm in the United States. The company has market cap of $478.88 million. It primarily acquires and manages mortgage-related assets, including residential mortgage-backed securities backed by prime jumbo, Alt-A, manufactured housing, and subprime residential mortgage loans; RMBS for which the principal and interest payments are guaranteed by the U.S. government agency or the U.S. government-sponsored entity; residential mortgage loans; commercial mortgage-backed securities; commercial mortgage loans and other commercial real estate debt; mortgage servicing rights; and real property and mortgage-related derivatives. It has a 21.89 P/E ratio. The firm also invests in corporate debt and equity securities, including distressed debt, collateralized loan obligations, and non-mortgage-related derivatives; and other financial assets, including private debt and equity investments in mortgage-related entities.

Investors sentiment is 1.64 in 2017 Q2. Its the same as in 2017Q1. It is flat, as 2 investors sold Ellington Financial LLC shares while 12 reduced holdings. only 11 funds opened positions while 12 raised stakes. 15.16 million shares or 2.53% less from 15.56 million shares in 2017Q1 were reported. Royal Savings Bank Of Canada invested 0% of its portfolio in Ellington Financial LLC (NYSE:EFC). Raymond James & Associates invested 0% of its portfolio in Ellington Financial LLC (NYSE:EFC). Optimum Advisors has 11,962 shares for 0.07% of their portfolio. Ellington Management Grp Limited Liability Corp reported 1.04 million shares stake. Reservoir L P reported 183,210 shares. Yorktown Mngmt & Research Company reported 0.7% of its portfolio in Ellington Financial LLC (NYSE:EFC). Wellington Management Group Llp reported 0.01% of its portfolio in Ellington Financial LLC (NYSE:EFC). Wells Fargo Communication Mn holds 0% or 17,383 shares. State Treasurer State Of Michigan accumulated 0.19% or 1.54M shares. Glenmede Na invested in 0% or 64 shares. Bb&T Ltd Liability Company has 47,142 shares. Nine Chapters Capital Mngmt Ltd has 10,600 shares. Petrus Trust Lta holds 0.59% in Ellington Financial LLC (NYSE:EFC) or 155,450 shares. Comml Bank Of America Corporation De owns 50,054 shares. Moreover, Tahithromos Ltd has 2.09% invested in Ellington Financial LLC (NYSE:EFC).

The stock increased 0.40% or $0.06 during the last trading session, reaching $14.91. About 104,745 shares traded or 20.09% up from the average. Ellington Financial LLC (NYSE:EFC) has declined 3.64% since December 6, 2016 and is downtrending. It has underperformed by 20.34% the S&P500.

Analysts await Ellington Financial LLC (NYSE:EFC) to report earnings on February, 12. They expect $0.27 earnings per share, 0.00% or $0.00 from last year’s $0.27 per share. EFC’s profit will be $8.67M for 13.81 P/E if the $0.27 EPS becomes a reality. After $0.24 actual earnings per share reported by Ellington Financial LLC for the previous quarter, Wall Street now forecasts 12.50% EPS growth.

ANI Pharmaceuticals, Inc., a specialty pharmaceutical company, develops, makes, and markets branded and generic prescription pharmaceuticals in the United States. The company has market cap of $787.30 million. It focuses on producing controlled substances, anti-cancer , hormones and steroids, and complex formulations. It has a 105.33 P/E ratio. The firm offers Erythromycin Ethylsuccinate to treat infections; Esterified Estrogen with Methyltestosterone for treating vasomotor symptoms of menopause; Etodolac to treat pain caused by osteoarthritis, rheumatoid arthritis, and other conditions; Fenofibrate for treating hypercholesterolemia; Flecainide to treat arrhythmia; Fluvoxamine for treating obsessive-compulsive and social anxiety disorders; and Hydrocortisone Enema and Cortenema to treat ulcerative colitis.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


Twitter Auto Publish Powered By : XYZScripts.com